Cleared Traditional

K844079 - NOVAMETRIX 860 PROTA. TRANSCUTANEOUS OXYGEN

K844079 is an FDA 510(k) clearance for NOVAMETRIX 860 PROTA. TRANSCUTANEOUS OXYGEN, manufactured by Novametrix Medical Systems, Inc.. The device is a Class 2 Anesthesiology device with product code KLK cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K844079 · Novametrix Medical Systems, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1984
Decision
42d
Days
Class 2
Risk

K844079 is an FDA 510(k) clearance for the NOVAMETRIX 860 PROTA. TRANSCUTANEOUS OXYGEN. Classified as Monitor, Oxygen, Cutaneous, For Infant Not Under Gas Anesthesia (product code KLK), Class II - Special Controls.

Submitted by Novametrix Medical Systems, Inc. (Wallingford, US). The FDA issued a Cleared decision on November 30, 1984 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2500 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Novametrix Medical Systems, Inc. devices

FDA 510(k) Submission Details - K844079

510(k) Number K844079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 1984
Decision Date November 30, 1984
Days to Decision 42 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d faster than avg
Panel avg: 140d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KLK Device Classification - Class 2, Special Controls

Product Code KLK Monitor, Oxygen, Cutaneous, For Infant Not Under Gas Anesthesia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - KLK Monitor, Oxygen, Cutaneous, For Infant Not Under Gas Anesthesia

All 32
Devices cleared under the same product code (KLK) and FDA review panel - the closest regulatory comparables to K844079.
HORIZON 2000 TRANSCUTANEOUS GAS MONITORING
K860124 · Mennen Medical, Inc. · May 1986
KONTRON CUTANEOUS PO2 MONITOR 820
K860951 · Kontron Instruments, Inc. · Apr 1986
NOVAMETRIX 811 TRANSCO2M PORTABLE TRANSCUTANEOUS 2
K844253 · Novametrix Medical Systems, Inc. · Jan 1985
NOVAMETRIX 850 TRANSCUTANEOUS OXYGEN
K842374 · Novametrix Medical Systems, Inc. · Sep 1984
TRANSCUTANEOUS 800-OXYGEN MONITORS/801
K840993 · Novametrix Medical Systems, Inc. · Apr 1984
MICRO SPAN TRANSCUTANEOUS OXYGEN MONIT
K840918 · Biochem International, Inc. · Apr 1984